16.8K(top 2%)
articles
623.7K(top 2%)
citations
4,612(top 2%)
★★ articles
222(top 2%)
★★★ articles
2.6(top 19%)
Avg IF
285(top 2%)
H-Index
465(top 2%)
G-Index
4,143
journals

Most Cited Articles of Royal Marsden Hospital in 2013

TitleJournalYearCitations
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateJournal of Clinical Oncology20132.6K
Metal-organic frameworks and self-assembled supramolecular coordination complexes: comparing and contrasting the design, synthesis, and functionality of metal-organic materialsChemical Reviews20132.3K
Alpha emitter radium-223 and survival in metastatic prostate cancerNew England Journal of Medicine20132.1K
A near-infrared fluorophore for live-cell super-resolution microscopy of cellular proteinsNature Chemistry2013607
Cancer heterogeneity: implications for targeted therapeuticsBritish Journal of Cancer2013549
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapyJournal of Clinical Oncology2013462
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trialLancet Oncology, The2013438
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2013390
Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatmentACS Nano2013386
In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 proceduresCirculation2013366
The clinical relevance of cancer cell linesJournal of the National Cancer Institute2013341
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007Thorax2013317
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study populationLancet Oncology, The2013266
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanomaCancer Discovery2013249
ZnO nanowire arrays for enhanced photocurrent in PbS quantum dot solar cellsAdvanced Materials2013226
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaAnnals of Oncology2013225
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2013223
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancerInvestigational New Drugs2013220
Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastasesEuropean Radiology2013217
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patientsJournal of Allergy and Clinical Immunology2013214
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized diseaseNeuro-Oncology2013195
Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasoundExperimental Neurology2013190
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2013185
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure TrialStroke2013167
Factors predicting late recurrence for estrogen receptor-positive breast cancerJournal of the National Cancer Institute2013156